Genesis DNA Overview
- Founded
- 2015
- Status
- Out of Business
- Employees
- 3
- Latest Deal Type
- Out of Business
Genesis DNA General Information
Description
Developer of a genome technology intended to make gene synthesis rapid, inexpensive, and sequence invariant. The company develops a technology that helps to convert digital text into physical DNA, thereby circumventing the cost, turnaround time, and sequence limiting factors of existing synthesis methods.
Contact Information
Primary Industry
Biotechnology
Primary Office
- Cambridge, MA
- United States
Genesis DNA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-May-2017 | 00000 | Completed | Out of Business | ||
| 4. Early Stage VC | 00000 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2016 | 00000 | Completed | Startup | ||
| 2. Accelerator/Incubator | 12-Sep-2015 | $20K | $250K | Completed | Startup | |
| 1. Accelerator/Incubator | 10-Sep-2015 | $250K | $250K | 00.000 | Completed | Startup |
Genesis DNA Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial